McKesson 2013 Annual Report Download - page 9

Download and view the complete annual report

Please find page 9 of the 2013 McKesson annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 128

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128

3
McKESSON CORPORATION
PART I
Item 1. Business.
General
McKesson Corporation (“McKesson,” the “Company,” the “Registrant” or “we” and other similar pronouns), is a
Fortune 14 corporation that delivers pharmaceuticals, medical supplies and healthcare information technology that make
healthcare safer while reducing costs.
The Company's fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references in this
document to a particular year shall mean the Company's fiscal year.
Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to
those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the
“Exchange Act,”) are available free of charge on our website (www.mckesson.com under the “Investors —Financial
Information —SEC Filings” caption) as soon as reasonably practicable after we electronically file such material with, or
furnish it to, the Securities and Exchange Commission (“SEC” or the “Commission”). The content on any website referred to
in this Annual Report on Form 10-K is not incorporated by reference into this report, unless expressly noted otherwise.
The public may also read or copy any materials that we file with the SEC at the SEC's Public Reference Room at 100 F
Street, N.E., Washington, DC 20549. The public may obtain information on the operation of the Public Reference Room by
calling the SEC at 1-800-SEC-0330. The SEC maintains a website that contains reports, proxy and information statements,
and other information regarding issuers, including the Company, that file electronically with the SEC. The address of the
website is www.sec.gov.
Business Segments
We operate in two segments. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs,
medical-surgical supplies and equipment and health and beauty care products throughout North America. This segment also
provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management,
technology, clinical support and business solutions to oncology and other specialty practices operating in the community
setting. In addition, this segment sells financial, operational and clinical solutions for pharmacies (retail, hospital, alternate
site) and provides consulting, outsourcing and other services. This segment includes a 49% interest in Nadro, S.A. de C.V.
(“Nadro”), a pharmaceutical distributor in Mexico.
The McKesson Technology Solutions segment delivers enterprise-wide clinical, patient care, financial, supply chain,
strategic management software solutions, pharmacy automation for hospitals, as well as connectivity, outsourcing and other
services, including remote hosting and managed services, to healthcare organizations. This segment also includes McKesson
Health Solutions, which includes our InterQual® clinical criteria solution, claims payment solutions and network performance
tools. This segment's customers include hospitals, physicians, homecare providers, retail pharmacies and payers from North
America, the United Kingdom, Ireland, other European countries and Israel.
Net revenues for our segments for the last three years were as follows:
Years Ended March 31,
(Dollars in billions)
2013 2012 2011
Distribution Solutions $119.1 97% $119.4 97% $ 108.9 97%
Technology Solutions 3.4 3% 3.3 3% 3.2 3%
Total $122.5 100% $122.7 100% $ 112.1 100%